Washington University School of Medicine in St. Louis has received a grant from the Centers for Disease Control and Prevention (CDC) to evaluate the effectiveness of vaccines against the SARS-CoV-2 virus among health-care personnel on the WashU Medical Campus and across BJC HealthCare. The study, which includes 16 sites across the country, will allow for … Continued
Doctors are running a clinical trial to see if a popular anti-depressant might keep someone from becoming severely ill with Covid-19. The researchers at Washington University of St. Louis are recruiting 1,100 people in the beginning stages of Covid-19 to test out the drug fluvoxamine, also known as Luvox.
New research — a deep dive into federal data by researchers at Washington University School of Medicine in St. Louis and Veterans Affairs St. Louis Health Care System — reveals a clearer distinction between the two contagious viruses: Among hospitalized patients, COVID-19 was associated with an increased need for ventilators, more admissions into intensive care … Continued
This summer, when bars and restaurants and stores began to reopen across the United States, people headed out despite the continuing threat of COVID-19. As a result, many areas, including the St. Louis region, saw increases in cases in July. Using mathematical modeling, new interdisciplinary research from the lab of Arye Nehorai, the Eugene & Martha … Continued
A model from Washington University in St. Louis predicts that the United States could nearly double in COVID-19 cases by Inauguration Day. The model predicts that the U.S. could reach 20 million cases by Jan. 20, CNN reports, nearly doubling the current 12.4 million infections already reported.
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen … Continued
A new study suggests that COVID-19 doesn’t infect the eye’s cornea. Although viruses such as herpes simplex can infect the cornea and Zika has been found in corneal tissue and tears, this does not appear to be the case with COVID-19, according to researchers from Washington University School of Medicine in St. Louis.
This episode of Show Me the Science highlights an effort led by scientists at Washington University in St. Louis to use computing power from around the world to identify vulnerabilities in the coronavirus.
Washington University School of Medicine announced on Friday a new clinical trial to investigate three anti-inflammatory drugs in patients with COVID-19. The trial, which is funded by the National Institutes of Health, aims to enroll 2,000 patients hospitalized with moderate to severe COVID-19, and is expected to last six months.
This episode of Show Me the Science focuses on a saliva test developed by Washington University School of Medicine scientists to detect the virus that causes COVID-19.